Evidence map›Paper›PMID 36943885›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Cryo-EM analyses of KIT and oncogenic mutants reveal structural oncogenic plasticity and a target for therapeutic intervention.

Stefan G Krimmer, Nicole Bertoletti, Yoshihisa Suzuki, Luka Katic, Jyotidarsini Mohanty, Sheng Shu, Sangwon Lee, Irit Lax, Wei Mi, Joseph Schlessinger

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. [Causal relationship between circulating cytokines and keloids: A Mendelian randomized study].Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Article
  6. Article
  7. A CanineAnimals : an open access journal from MDPI · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Stefan G KrimmerDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0002-5669-9071
Nicole BertolettiDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0001-5167-402X
Yoshihisa SuzukiDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0003-4640-5305
Luka KaticDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
Jyotidarsini MohantyDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
Sheng ShuDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
Sangwon LeeDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0002-9441-6546
Irit LaxDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
Wei MiDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.
Joseph SchlessingerDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520.ORCID 0000-0002-5085-5969
Yale University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The receptor tyrosine kinase KIT and its ligand stem cell factor (SCF) are required for the development of hematopoietic stem cells, germ cells, and other cells. A variety of human cancers, such as acute myeloid leukemia, gastrointestinal stromal tumor, and mast cell leukemia, are driven by somatic gain-of-function KIT mutations. Here, we report cryo electron microscopy (cryo-EM) structural analyses of full-length wild-type and two oncogenic KIT mutants, which show that the overall symmetric arrangement of the extracellular domain of ligand-occupied KIT dimers contains asymmetric D5 homotypic contacts juxtaposing the plasma membrane. Mutational analysis of KIT reveals in D5 region an "Achilles heel" for therapeutic intervention. A ligand-sensitized oncogenic KIT mutant exhibits a more comprehensive and stable D5 asymmetric conformation. A constitutively active ligand-independent oncogenic KIT mutant adopts a V-shaped conformation solely held by D5-mediated contacts. Binding of SCF to this mutant fully restores the conformation of wild-type KIT dimers, including the formation of salt bridges responsible for D4 homotypic contacts and other hallmarks of SCF-induced KIT dimerization. These experiments reveal an unexpected structural plasticity of oncogenic KIT mutants and a therapeutic target in D5.

Indexed as

NeoplasmsProto-Oncogene Proteins c-kitCryoelectron MicroscopyHumansLigandsPhosphorylationReceptor Protein-Tyrosine KinasesStem Cell FactorLigandsProto-Oncogene Proteins c-kitReceptor Protein-Tyrosine KinasesStem Cell Factorcell signalingcryo-EMmechanism of activationoncogenic mutantreceptor tyrosine kinase

Identifiers

PMID36943885
PMCPMC10068818
OpenAlexW4328048259

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.